One of the listed companies, Silco Pharmaceuticals Limited discloses its financial reports for the second quarter, (October – December 23).
The company’s earnings per share (EPS) Tk 0.12 paisa in Q2 of the current financial year (October – December 23). EPS was Tk 0.15 paisa during the same period last year. NAV per share was Tk. 22.64 as of December 31, 2023.
Share this
